New Concepts on Vaccine Development for the Poultry Diseases

  • Han, M.G. (Avian Diseases Division, National Veterinary Research and Quarantine Service, Ministry of Agriculture and Forestry)
  • Published : 2001.08.01

Abstract

Vaccination is one of the most important and cost-effective methods of preventing infectious diseases. Over the past decade, scientific in molecular biology and immunology have improved understanding of many diseases and led to the development of novel strategies for vaccination. An ideal vaccine would induce effective immunity specific for the type of infection, have long duration, require minimal or no boosters, have safety, would not induce adverse reaction, and be easy to administer. The desire to meet these criteria has resulted in the development of vaccines that do not depend on the use of the viable disease agent. It is not the intent of this review to give an extensive review of the field of vaccinology, but rather to address characteristics of conventional and genetically engineered vaccines.

Keywords

References

  1. Vaccine v.17 Broadening the approaches to developing more effective vaccines Babiuk,L.A.
  2. Vet Immunol Immunopath v.72 Immunization of animals: from DNA to the dinner plate Babiuk,L.A.;Hurk,S.D.;Babiuk,S.L.
  3. Adv Drug Del Rev v.38 Vaccine delivery to animals Bowersock,T.L.;Martin,S.
  4. Trends Plant Sci v.6 Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants Daniel,H.;Streatfield,S.J.;Wycoff,K.
  5. Plasmid v.39 Genetically engineered vaccines: An overview Dertzbaugh,M.T.
  6. Vaccine v.17 New technologies fir making vaccines Ellis,R.W.
  7. Vaccine v.19 Product development plan for new vaccine technologies Ellis,R.W.
  8. Ach Virol v.145 Oral immunogenicity of the plant derived spike protein from swine transmissible gastroenteritis coronavirus Gomez,A.;Wigdorovitz,A.;Castanon,S.;Gil,F.;Ordas,R.;Borca,M.V.;Escibano,J.M.
  9. Biotechnol Appl Biochem v.32 Design and production of recombinant subunit vaccines Hanson,M.;Nygren,P.;Stahl,S.
  10. Biotechnol Appl Biochem v.32 Design and production of recombinant subunit vaccines Hansson,M.;Nyren,P.;Stahl,S.
  11. Adv Drug Del Rev v.43 Current status of DNA vaccines in veterinary medicine Krishnan,B.R.
  12. Vaccine v.18 DNA and RNA-based vaccine: principles, progress and prospects Leitner,W.W.;Ying,H.;Restifo,N.P.
  13. J Biotech v.73 Production of recombinant subunit vacciens:protein immunogens, live delivery systems and nucleic acid vacciens Lilijeqvist,S.;Stahl,S.
  14. Vaccine v.19 Use of live bacterial vaccine vectors for antigen delivery: potential and limitations Medina,E.;Guzman,C.A.
  15. Trends Microbiol v.6 Perspective: edible vaccines-a concept coming of age Mor,T.S.;Gomez-Lim,M.A.;Palmer,K.E.
  16. Mol Med Today v.6 Recent advances with recombinant bacterial vaccine vectors Shata,M.T.;Stevceva,L.;Agwale,S.;Lewis,G.K.;Hone,D.M.
  17. Science v.259 Heterologous protection against influenza by injection of DNA encoding a viral protein Ulmer,J.B.;Donnely,J.J.;Parker,S.E.;Rhodes,G.H.;Felgner,P.L.;Dwarki,V.J.;Gromkowski,S.H.;Deck,R.R.;Dewitt,C.M.;Friedman,A.;Hawe,L.A.;Leander,K.A.;Martinez,D.;Perry,H.C.;Shiver,J.W.;Montgomery,D.L.;Liu,M.A.
  18. Curr Op Biotech v.11 Plants for delivery of edible vaccines Walmsley,A.M.;Arntzen,C.